Cargando…
Pulmonary alveolar proteinosis: from classification to therapy
Pulmonary alveolar proteinosis (PAP) is a rare respiratory syndrome characterised by the accumulation of surfactant lipoproteins within the alveoli. According to various pathogenetic mechanisms and aetiologies, PAP is classified as primary, secondary or congenital. Primary PAP is led by a granulocyt...
Autores principales: | Salvaterra, Elena, Campo, Ilaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341616/ https://www.ncbi.nlm.nih.gov/pubmed/32684997 http://dx.doi.org/10.1183/20734735.0018-2020 |
Ejemplares similares
-
Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
por: Campo, Ilaria, et al.
Publicado: (2012) -
A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP)
por: Mariani, Francesca, et al.
Publicado: (2022) -
Pulmonary alveolar proteinosis in children
por: Bush, Andrew, et al.
Publicado: (2020) -
Assessment and management of pulmonary alveolar proteinosis in a reference center
por: Campo, Ilaria, et al.
Publicado: (2013) -
Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
por: Piccoli, Luca, et al.
Publicado: (2015)